ZP
AZN icon

Zimmer Partners’s AstraZeneca AZN Stock Holding History

Zimmer Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,100
Closed -$8.3M – 127
2025
Q3 		$8.3M Buy
+54,100
New +$8.19M 0.18% 86
2024
Q3 		– Sell
-100,500
Closed -$15.7M – 155
2024
Q2 		$15.7M Sell
100,500
-36,950
-27% -$5.56M 0.29% 59
2024
Q1 		$18.6M Buy
137,450
+28,350
+26% +$3.75M 0.4% 47
2023
Q4 		$14.7M Buy
109,100
+71,600
+191% +$9.31M 0.54% 37
2023
Q3 		$5.08M Buy
37,500
+15,100
+67% +$2.06M 0.13% 77
2023
Q2 		$3.21M Buy
+22,400
New +$3.3M 0.08% 84

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Zimmer Partners's AZN Position: Q4 2025 in Review

Zimmer Partners sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 54,100 shares — an estimated $8.3M sold.

Zimmer Partners first reported a position in AZN in Q2 2023 and held it in 6 quarters. The position peaked at $18.6M in Q1 2024. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Zimmer Partners reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Zimmer Partners sold 54,100 AstraZeneca shares in Q4 2025, an estimated $8.3M.
  • Zimmer Partners first reported a position in AstraZeneca in Q2 2023 and held it in 6 quarters.
  • Zimmer Partners's AstraZeneca position peaked at $18.6M in Q1 2024.
  • 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Zimmer Partners's 13F filing for Q4 2025, filed 17 Feb 2026.